American Oriental Bioengineering to Report Third Quarter 2009 Financial Results on November 16, 2009

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Acquisitor(Ber)	LSE:AOB	London	Ordinary Share	BMG0074J1027	ORD 1P

Share Name

Share Symbol

Market

Type

Share ISIN

Share Description

Acquisitor(Ber)

LSE:AOB

London

Ordinary Share

BMG0074J1027

ORD 1P

Price Change

% Change

Share Price

Bid Price

Offer Price

High Price

Low Price

Open Price

Shares Traded

Last Trade

0.00

0.00%

0.00

Industry Sector	Turnover	Profit	EPS - Basic	PE Ratio	Market Cap
	0	0		N/A	0

Industry Sector

Turnover

Profit

EPS - Basic

PE Ratio

Market Cap

N/A

American Oriental Bioengineering to Report Third Quarter 2009 Financial Results on November 16, 2009

09/11/2009 9:01pm

PR Newswire (US)

Acquisitor(Ber) (LSE:AOB)
Historical Stock Chart

From May 2019 to May 2024

Click Here for more Acquisitor(Ber) Charts.

NEW YORK, Nov. 9 /PRNewswire-Asia-FirstCall/ -- American Oriental Bioengineering, Inc. (NYSE:AOB), ("the Company" or "AOBO"), a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter ("OTC") products, today announced that it plans to release third quarter 2009 financial results on Monday, November 16, 2009, after the market closes. The Company will hold a conference call at 8:00 am ET on Tuesday, November 17, 2009 to discuss third quarter 2009 results. Listeners may access the call by dialing 1-866-770-7051 or 1-617-213-8064 for international callers, access code: 89648638. A webcast will also be available through AOB's website at http://www.bioaobo.com/ . A replay of the call will be available through November 24, 2009. Listeners may access the replay by dialing 1-888-286-8010 or 1-617-801-6888 for international callers, access code: 58148119. About American Oriental Bioengineering, Inc. American Oriental Bioengineering, Inc. is a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter products. DATASOURCE: American Oriental Bioengineering, Inc. CONTACT: Integrated Corporate Relations, Inc., Ashley M. Ammon, +1-646-277-1200

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

AOB Acquisitor(Ber)